Johnson & Johnson’s Janssen COVID-19 Vaccine: CDC and FDA have recommended a pause in the use of Johnson & Johnson’s J&J/Janssen COVID-19 Vaccine in the United States out of an abundance of caution, effective Tuesday, April 13. The Advisory Committee on Immunization Practices (ACIP) will hold its second emergency meeting to discuss J&J/Janssen COVID-19 Vaccine on April 23, 2021. People who have received the J&J/Janssen COVID-19 Vaccine within the past three weeks who develop severe headache, abdominal pain, leg pain, or shortness of breath should seek medical care right away.
Vaccines for COVID-19
COVID-19 vaccines are safe and effective. After you’ve been fully vaccinated, you can start to do some things that you had to stop doing because of the pandemic. Key Things to Know
YOUR VACCINATION WHEN FULLY VACCINATED FOR HEALTHCARE WORKERSTotal Doses Distributed
Total Doses Administered
Healthcare Workers
Toolkits and resources for handling, storing, and administering the vaccine, including patient education materials.
Healthcare Workers
Toolkits and resources for handling, storing, and administering the vaccine, including patient education materials.
Professional Resources
- Federal Retail Pharmacy Program for COVID-19 Vaccination
- Interim Clinical Considerations for Use of mRNA COVID-19 Vaccine
- Communication Resources
- Advisory Committee on Immunization Practices
- V-safe Information Sheet pdf icon[700 KB, 2 pages]
- Combat COVID: Information about Clinical Trialsexternal icon